# Drug Use Investigation of Kaletra

> **NCT01076972** · — · COMPLETED · sponsor: **Abbott** · enrollment: 1184 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Lopinavir/ritonavir (Kaletra)

## Key facts

- **NCT ID:** NCT01076972
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 1184 (ACTUAL)
- **Last updated:** 2012-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076972, "Drug Use Investigation of Kaletra". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01076972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*